Autogenous Vaccines Market size was valued at USD 121.4 million in 2021 and is expected to grow at a CAGR of 5.8% from 2022-2028. Autogenous vaccines are established from the destruction and isolation of micro-organisms in diseased animals either individual animals or herds and are utilized to offer immunity to the same animals. These animal vaccines are primarily derivate from viral or bacterial strains. These demonstrate to be an advantageous option when there is no vaccine accessible for viral or bacterial infections, or in cases where present vaccines are not operative. Autogenous vaccines are permitted for use under the surveillance of a veterinarian or by government-assigned non-veterinarians.